July 2026– date –
-
Xsensio Achieves Key Milestones with ‘Lab-on-Skin®’ Platform, Advancing Continuous Multi-Biomarker Wearable Monitoring for Personalized Healthcare
Propel(x) Switzerland Overview Wearable health monitoring company Xsensio achieved significant milestones in 2026, enhancing sensor integration and device performance through collaborations for its continuous monitoring solutions. The CE... -
Trinity Biotech and Latch Medical Forge Alliance for AI-Powered Precision Intradermal Drug Delivery in Metabolic Disorders
GlobeNewswire (via Trinity Biotech plc) Ireland Overview Trinity Biotech has announced a strategic partnership with Latch Medical, integrating Trinity's AI-native CGM+ wearable biosensor platform with Latch Medical's innovative intraderm... -
Premier Food Safety Conference 2026 Highlights Advanced Biosensors & Portable On-Site Testing for Real-Time Contaminant Detection, Ushering in New Era of Food Safety
Food Science Conferences International Overview The Premier Food Safety Conference 2026 emphasized rapid detection methods as a key topic for food safety, focusing on advanced biosensors, molecular technologies, immunoassays, and portabl... -
Chitosan Hydrogel and Carboxylated Carbon Nanotubes Integrate to Create Highly Stable, Sensitive Red Blood Cell Biosensors for Organophosphate Pesticide Detection
Mirage News International Overview Researchers have developed a novel bio-based strategy using chitosan hydrogel to significantly enhance the stability and selectivity of red blood cell membranes in biosensors. By integrating carboxylate... -
Roche Unveils AXELIOS 1 Next-Gen Sequencing Platform and cobas® Mass Spec at ADLM 2026, Addressing Lab Workforce & Workflow Challenges
PR Newswire (via Roche) Switzerland Overview Roche showcased advanced integrated diagnostic solutions at ADLM 2026, featuring the new AXELIOS 1 next-generation sequencing platform and cobas® Mass Spec solution. These innovations aim to e... -
UT Southwestern Develops Novel Biosensor to Track α-Ketoglutarate, Unraveling Mechanisms of Severe Childhood Brain Disorder and Suggesting Early Intervention
UT Southwestern Medical Center USA Overview Researchers at UT Southwestern's Children's Medical Center Research Institute have developed a novel biosensor capable of tracking alpha-ketoglutarate (αKG), a critical metabolite. Published in... -
Roche Reports 6% H1 2026 Sales Growth, Secures CE Marks for New Alzheimer’s and TB Blood Tests, Acquires AI Pathology Firm PathAI
Roche (Official Press Release), Fierce Biotech Switzerland Overview Roche reported robust 6% sales growth in H1 2026 at constant exchange rates, with diagnostics contributing 3% despite healthcare price reforms in China. Key advancements... -
Dexcom Selected as First Participant in FDA’s TEMPO Pilot Program to Advance AI-Powered Glucose Health for Early Prediabetes & T2D Intervention
Business Wire (via Dexcom Investor Relations) USA Overview Dexcom has been selected as the inaugural participant in the FDA's TEMPO (Technology-Enabled Meaningful Patient Outcomes) digital health devices pilot program, aiming to accelera... -
Lidsen Paper Details Advances in Gold Nanoparticles-Based Colorimetric Assays Using Aptamers for Rapid Food Detection
Lidsen International Overview Research published in Lidsen discusses advancements in gold nanoparticles-based colorimetric assays using aptamers for rapid food detection. It emphasizes how aptamers, as biorecognition elements, combined w... -
bioRxiv: SMART-NeuroDx Achieves Reagent-Free, ML-Driven 4-Analyte Dementia Screening with LoD of 0.087 pg/mL
bioRxiv USA Overview A preprint published on bioRxiv on July 23, 2026, describes SMART-NeuroDx, a reagent-free multianalyte biosensor platform with machine-learning (ML) readout. Aimed at point-of-care dementia screening, this platform a...
